Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Non-Current Debt (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Non-Current Debt data on record, last reported at $107.0 million in Q4 2025.

  • For Q4 2025, Non-Current Debt fell 6.14% year-over-year to $107.0 million; the TTM value through Dec 2025 reached $107.0 million, down 6.14%, while the annual FY2025 figure was $87.0 million, 69.18% down from the prior year.
  • Non-Current Debt reached $107.0 million in Q4 2025 per PAHC's latest filing, down from $115.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $304.7 million in Q3 2023 and bottomed at $87.0 million in Q2 2025.
  • Average Non-Current Debt over 5 years is $179.1 million, with a median of $168.0 million recorded in 2022.
  • Peak YoY movement for Non-Current Debt: surged 187.29% in 2022, then crashed 69.18% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $107.0 million in 2021, then skyrocketed by 71.96% to $184.0 million in 2022, then decreased by 17.93% to $151.0 million in 2023, then dropped by 24.5% to $114.0 million in 2024, then fell by 6.14% to $107.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $107.0 million in Q4 2025, $115.0 million in Q3 2025, and $87.0 million in Q2 2025.